February 2020

OPHTHALMOLOGY

RHO KINASE INHIBITORS AS A NOVEL TREATMENT FOR GLAUCOMA AND OCULAR HYPERTENSION

Featuring: Angelo P. Tanna, MD

Episode Summary

Angelo P. Tanna, MD, shares the biggest challenges ophthalmologists face when treating glaucoma and ocular hypertension. He discusses his recently published review of Rho Kinase Inhibitors as a novel treatment for Glaucoma and Ocular Hypertension. 
Angelo P. Tanna, MD, vice chair and professor in the Department of Ophthalmology at Northwestern Medicine. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like